Tower Research Capital (TRC)’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Buy
7,476
+6,174
+474% +$98.4K ﹤0.01% 2145
2025
Q4
$21.1K Sell
1,302
-3,663
-74% -$59.8K ﹤0.01% 3062
2025
Q3
$74.3K Sell
4,965
-16,324
-77% -$199K ﹤0.01% 2233
2025
Q2
$248K Sell
21,289
-7,182
-25% -$65.2K 0.01% 1589
2025
Q1
$212K Buy
28,471
+27,791
+4,087% +$214K 0.01% 1338
2024
Q4
$4.08K Sell
680
-15,111
-96% -$83.3K ﹤0.01% 4521
2024
Q3
$80.8K Buy
15,791
+1,225
+8% +$5.34K ﹤0.01% 2394
2024
Q2
$52.7K Buy
14,566
+13,384
+1,132% +$42.5K ﹤0.01% 3067
2024
Q1
$3.79K Sell
1,182
-78,361
-99% -$303K ﹤0.01% 4792
2023
Q4
$390K Buy
79,543
+69,431
+687% +$317K ﹤0.01% 1573
2023
Q3
$55.1K Sell
10,112
-3,283
-25% -$21.7K ﹤0.01% 2463
2023
Q2
$89.9K Sell
13,395
-25,583
-66% -$190K ﹤0.01% 2108
2023
Q1
$344K Buy
38,978
+38,128
+4,486% +$336K 0.01% 1058
2022
Q4
$6K Sell
850
-19,264
-96% -$150K ﹤0.01% 4675
2022
Q3
$143K Buy
20,114
+16,369
+437% +$154K ﹤0.01% 2230
2022
Q2
$30K Sell
3,745
-17,095
-82% -$150K ﹤0.01% 3364
2022
Q1
$290K Buy
20,840
+20,026
+2,460% +$315K ﹤0.01% 1484
2021
Q4
$23K Sell
814
-560
-41% -$17.2K ﹤0.01% 3496
2021
Q3
$47K Sell
1,374
-7,734
-85% -$280K ﹤0.01% 3009
2021
Q2
$372K Buy
9,108
+7,649
+524% +$297K 0.01% 1422
2021
Q1
$59K Sell
1,459
-4,401
-75% -$238K ﹤0.01% 2976
2020
Q4
$347K Buy
5,860
+4,886
+502% +$252K 0.01% 1284
2020
Q3
$47K Sell
974
-632
-39% -$26.6K ﹤0.01% 3560
2020
Q2
$78K Buy
+1,606
New +$58.6K ﹤0.01% 2671
2019
Q4
Sell
-54
Closed -$2K 3450
2019
Q3
$2K Buy
+54
New +$2.2K ﹤0.01% 3647

Other funds holding ADPT